Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Vaccines

  Free Subscription


Articles published in Arch Virol

Retrieve available abstracts of 59 articles:
HTML format
Text format



Single Articles


    July 2018
  1. EL-DABAE WH, Hussein HA, Rohaim MA, El-Safty MM, et al
    Saponin-adjuvanted vaccine protects chickens against velogenic Newcastle disease virus.
    Arch Virol. 2018 Jul 2. pii: 10.1007/s00705-018-3917.
    PubMed     Text format     Abstract available


  2. SANTOS MR, Assao VS, Santos FAA, Salgado RL, et al
    Utilization of phage display to identify antigenic regions in the PCV2 capsid protein for the evaluation of serological responses in mice and pigs.
    Arch Virol. 2018;163:1877-1887.
    PubMed     Text format     Abstract available


  3. WANG X, Dong K, Long M, Lin F, et al
    Induction of a high-titered antibody response using HIV gag-EV71 VP1-based virus-like particles with the capacity to protect newborn mice challenged with a lethal dose of enterovirus 71.
    Arch Virol. 2018;163:1851-1861.
    PubMed     Text format     Abstract available


  4. KITAB B, Kohara M, Tsukiyama-Kohara K
    Experimental in vitro and in vivo systems for studying the innate immune response during dengue virus infections.
    Arch Virol. 2018;163:1717-1726.
    PubMed     Text format     Abstract available


    June 2018
  5. EL NAGGAR RF, Rohaim MA, Bazid AH, Ahmed KA, et al
    Biological characterization of wild-bird-origin avian avulavirus 1 and efficacy of currently applied vaccines against potential infection in commercial poultry.
    Arch Virol. 2018 Jun 19. pii: 10.1007/s00705-018-3916.
    PubMed     Text format     Abstract available


    May 2018
  6. LIN W, Lu P, Li A, Wu Y, et al
    Assessing the efficacy of a live vaccine against avian encephalomyelitis virus.
    Arch Virol. 2018 May 16. pii: 10.1007/s00705-018-3862.
    PubMed     Text format     Abstract available


  7. SULCZEWSKI FB, Liszbinski RB, Romao PRT, Rodrigues Junior LC, et al
    Nanoparticle vaccines against viral infections.
    Arch Virol. 2018 May 4. pii: 10.1007/s00705-018-3856.
    PubMed     Text format     Abstract available


    April 2018
  8. LIU C, Liu Y, Chen H, Feng H, et al
    Genetic and immunogenicity analysis of porcine circovirus type 2 strains isolated in central China.
    Arch Virol. 2018;163:937-946.
    PubMed     Text format     Abstract available


    February 2018
  9. MOZHGANI SH, Malekpour SA, Norouzi M, Ramezani F, et al
    Molecular evolution and phylodynamics of hepatitis B virus infection circulating in Iran.
    Arch Virol. 2018 Feb 13. pii: 10.1007/s00705-018-3764.
    PubMed     Text format     Abstract available


    January 2018
  10. KUMAR B, Asha K, Khanna M, Ronsard L, et al
    The emerging influenza virus threat: status and new prospects for its therapy and control.
    Arch Virol. 2018 Jan 10. pii: 10.1007/s00705-018-3708.
    PubMed     Text format     Abstract available


    December 2017
  11. KHODAMORADI S, Shenagari M, Kheiri MT, Sabahi F, et al
    IRES-based co-expression of influenza virus conserved genes can promote synergistic antiviral effects both in vitro and in vivo.
    Arch Virol. 2017 Dec 21. pii: 10.1007/s00705-017-3682.
    PubMed     Text format     Abstract available


  12. YUAN X, Lin H, Li B, He K, et al
    Efficacy and immunogenicity of recombinant swinepox virus expressing the truncated S protein of a novel isolate of porcine epidemic diarrhea virus.
    Arch Virol. 2017;162:3779-3789.
    PubMed     Text format     Abstract available


  13. ZAIDI SSZ, Hameed A, Ali N, Umair M, et al
    A measles outbreak in Sindh, Pakistan caused by a genotype B3 virus.
    Arch Virol. 2017;162:3603-3610.
    PubMed     Text format     Abstract available


    November 2017
  14. BAGHBAN RAHIMI S, Mohebbi A, Vakilzadeh G, Biglari P, et al
    Enhancement of therapeutic DNA vaccine potency by melatonin through inhibiting VEGF expression and induction of antitumor immunity mediated by CD8+ T cells.
    Arch Virol. 2017 Nov 17. doi: 10.1007/s00705-017-3647.
    PubMed     Text format     Abstract available


    October 2017
  15. KRISHNAVAJHALA HR, Williams J, Heidner H
    An influenza A virus vaccine based on an M2e-modified alphavirus.
    Arch Virol. 2017 Oct 27. doi: 10.1007/s00705-017-3578.
    PubMed     Text format     Abstract available


    September 2017
  16. TURMAGAMBETOVA AS, Alexyuk PG, Bogoyavlenskiy AP, Zaitseva IA, et al
    Adjuvant activity of saponins from Kazakhstani plants on the immune responses to subunit influenza vaccine.
    Arch Virol. 2017 Sep 21. doi: 10.1007/s00705-017-3560.
    PubMed     Text format     Abstract available


    August 2017
  17. SONG Y, Fan Z, Zuo Y, Wei H, et al
    Binding of rabbit hemorrhagic disease virus-like particles to host histo-blood group antigens is blocked by antisera from experimentally vaccinated rabbits.
    Arch Virol. 2017 Aug 5. doi: 10.1007/s00705-017-3509.
    PubMed     Text format     Abstract available


  18. ZHUGUNISSOV K, Bulatov Y, Taranov D, Yershebulov Z, et al
    Protective immune response of oral rabies vaccine in stray dogs, corsacs and steppe wolves after a single immunization.
    Arch Virol. 2017 Aug 1. doi: 10.1007/s00705-017-3499.
    PubMed     Text format     Abstract available


    July 2017
  19. ORABI A, Hussein A, Saleh AA, El-Magd MA, et al
    Evolutionary insights into the fusion protein of Newcastle disease virus isolated from vaccinated chickens in 2016 in Egypt.
    Arch Virol. 2017 Jul 8. doi: 10.1007/s00705-017-3483.
    PubMed     Text format     Abstract available


  20. WANG H, Guo S, Li Z, Xu X, et al
    Suspension culture process for H9N2 avian influenza virus (strain Re-2).
    Arch Virol. 2017 Jul 7. doi: 10.1007/s00705-017-3460.
    PubMed     Text format     Abstract available


    June 2017
  21. FENG S, Wang C, Hu S, Wu Q, et al
    Recent progress in the development of white spot syndrome virus vaccines for protecting shrimp against viral infection.
    Arch Virol. 2017 Jun 24. doi: 10.1007/s00705-017-3450.
    PubMed     Text format     Abstract available


  22. LEITE FGG, Torres AA, De Oliveira LC, Da Cruz AFP, et al
    c-Jun integrates signals from both MEK/ERK and MKK/JNK pathways upon vaccinia virus infection.
    Arch Virol. 2017 Jun 15. doi: 10.1007/s00705-017-3446.
    PubMed     Text format     Abstract available


  23. SHARMA KK, Kalyani IH, Mohapatra J, Patel SD, et al
    Evaluation of the oncolytic potential of R2B Mukteshwar vaccine strain of Newcastle disease virus (NDV) in a colon cancer cell line (SW-620).
    Arch Virol. 2017 Jun 3. doi: 10.1007/s00705-017-3411.
    PubMed     Text format     Abstract available


    May 2017
  24. XIAO X, Zhang Y, Wei Q, Yin X, et al
    Flagellin FljB as an adjuvant to the recombinant adenovirus rabies glycoprotein vaccine increases immune responses against rabies in mice.
    Arch Virol. 2017 May 26. doi: 10.1007/s00705-017-3413.
    PubMed     Text format     Abstract available


  25. LEITE FGG, Bergthaler A, Skern T
    Vaccinia virus G1 protein: absence of autocatalytic self-processing.
    Arch Virol. 2017 May 18. doi: 10.1007/s00705-017-3409.
    PubMed     Text format     Abstract available


    April 2017
  26. RODRIGUEZ LAY LLA, Bello Corredor M, Montalvo Villalba MC, Chibas Ojeda AG, et al
    Hepatitis B virus infection assessed 3 to 18 years after vaccination in Cuban children and adolescents born to HBsAg-positive mothers.
    Arch Virol. 2017 Apr 24. doi: 10.1007/s00705-017-3365.
    PubMed     Text format     Abstract available


  27. VALDES I, Marcos E, Suzarte E, Perez Y, et al
    A dose-response study in mice of a tetravalent vaccine candidate composed of domain III-capsid proteins from dengue viruses.
    Arch Virol. 2017 Apr 9. doi: 10.1007/s00705-017-3360.
    PubMed     Text format     Abstract available


  28. COSTA GB, Lavergne A, Darcissac E, Lacoste V, et al
    Absence of vaccinia virus detection in a remote region of the Northern Amazon forests, 2005-2015.
    Arch Virol. 2017 Apr 7. doi: 10.1007/s00705-017-3353.
    PubMed     Text format     Abstract available


  29. YOGISHARADHYA R, Kumar A, Ramappa R, Venkatesan G, et al
    Functional characterization of recombinant major envelope protein (rB2L) of orf virus.
    Arch Virol. 2017;162:953-962.
    PubMed     Text format     Abstract available


    March 2017
  30. SHAH MS, Ashraf A, Khan MI, Rahman M, et al
    Fowl adenovirus: history, emergence, biology and development of a vaccine against hydropericardium syndrome.
    Arch Virol. 2017 Mar 10. doi: 10.1007/s00705-017-3313.
    PubMed     Text format     Abstract available


    February 2017
  31. KWAK BO, Lee HJ, Kang HM, Oh CE, et al
    Genotype analysis of ORF 62 identifies varicella-zoster virus infections caused by a vaccine strain in children.
    Arch Virol. 2017 Feb 15. doi: 10.1007/s00705-017-3276.
    PubMed     Text format     Abstract available


  32. WU W, Liu S, Yu P, Tao X, et al
    Role of systemic injection of rabies immunoglobulin in rabies vaccination.
    Arch Virol. 2017 Feb 10. doi: 10.1007/s00705-017-3263.
    PubMed     Text format     Abstract available


  33. ZHANG M, Ge J, Wen Z, Chen W, et al
    Characterization of a recombinant Newcastle disease virus expressing the glycoprotein of bovine ephemeral fever virus.
    Arch Virol. 2017;162:359-367.
    PubMed     Text format     Abstract available


    January 2017
  34. FOTOUHI F, Shaffifar M, Farahmand B, Shirian S, et al
    Adjuvant use of the NKT cell agonist alpha-galactosylceramide leads to enhancement of M2-based DNA vaccine immunogenicity and protective immunity against influenza A virus.
    Arch Virol. 2017 Jan 24. doi: 10.1007/s00705-017-3230.
    PubMed     Text format     Abstract available


    December 2016
  35. ANDOH K, Yamazaki K, Honda Y, Honda T, et al
    Turkey herpesvirus with an insertion in the UL3-4 region displays an appropriate balance between growth activity and antibody-eliciting capacity and is suitable for the establishment of a recombinant vaccine.
    Arch Virol. 2016.
    PubMed     Text format     Abstract available


    November 2016
  36. MOEINI S, Saeidi M, Fotouhi F, Mondanizadeh M, et al
    Erratum to: Synergistic effect of programmed cell death protein 1 blockade and secondary lymphoid tissue chemokine in the induction of anti-tumor immunity by a therapeutic cancer vaccine.
    Arch Virol. 2016.
    PubMed     Text format    


  37. ZHOU Y, Yang X, Wang H, Zeng F, et al
    The establishment and characteristics of cell-adapted IBV strain H120.
    Arch Virol. 2016;161:3179-87.
    PubMed     Text format     Abstract available


    October 2016
  38. ASTRAY RM, Jorge SA, Pereira CA
    Rabies vaccine development by expression of recombinant viral glycoprotein.
    Arch Virol. 2016.
    PubMed     Text format     Abstract available


  39. LI J, Yu T, Zhang F, Wang X, et al
    Inactivated chimeric porcine circovirus (PCV) 1-2 vaccines based on genotypes 2b and 2d exhibit similar immunological effectiveness in protecting pigs against challenge with PCV2b strain 0233.
    Arch Virol. 2016.
    PubMed     Text format     Abstract available


  40. MIAO FM, Zhang SF, Wang SC, Liu Y, et al
    Comparison of immune responses to attenuated rabies virus and street virus in mouse brain.
    Arch Virol. 2016.
    PubMed     Text format     Abstract available


  41. SUN Y, Yang C, Li J, Li L, et al
    Construction of a recombinant duck enteritis virus vaccine expressing hemagglutinin of H9N2 avian influenza virus and evaluation of its efficacy in ducks.
    Arch Virol. 2016.
    PubMed     Text format     Abstract available


  42. MOEINI S, Saeidi M, Fotouhi F, Mondanizdeh M, et al
    Synergistic effect of programmed cell death protein 1 blockade and secondary lymphoid tissue chemokine in the induction of anti-tumor immunity by a therapeutic cancer vaccine.
    Arch Virol. 2016.
    PubMed     Text format     Abstract available


    September 2016
  43. MADAPONG A, Temeeyasen G, Saeng-Chuto K, Tripipat T, et al
    Humoral immune responses and viral shedding following vaccination with modified live porcine reproductive and respiratory syndrome virus vaccines.
    Arch Virol. 2016.
    PubMed     Text format     Abstract available


  44. AGHASADEGHI MR, Velayati AA, Mamishi S, Nabavi M, et al
    Low prevalence of hepatitis B vaccine escape mutants among individuals born after the initiation of a nationwide vaccination program in Iran.
    Arch Virol. 2016.
    PubMed     Text format     Abstract available


  45. ZHU Y, Wang GH, Cui YD, Cui SJ, et al
    Establishment of a nanoparticle-assisted RT-PCR assay to distinguish field strains and attenuated strains of porcine epidemic diarrhea virus.
    Arch Virol. 2016;161:2543-7.
    PubMed     Text format     Abstract available


    July 2016
  46. ANDRADE LG, Albarnaz JD, Mugge FL, David BA, et al
    Vaccinia virus dissemination requires p21-activated kinase 1.
    Arch Virol. 2016.
    PubMed     Text format     Abstract available


  47. SAMY A, El-Enbaawy MI, El-Sanousi AA, Nasef SA, et al
    Initiation and regulation of immune responses to immunization with whole inactivated vaccines prepared from two genetically and antigenically distinct lineages of Egyptian influenza A virus subtype H5N1.
    Arch Virol. 2016.
    PubMed     Text format     Abstract available


  48. QUINTILIO W, de Freitas FA, Rodriguez D, Kubrusly FS, et al
    Vitamins as influenza vaccine adjuvant components.
    Arch Virol. 2016.
    PubMed     Text format     Abstract available


  49. NAVID MT, Li Y, Zhou M, Cui M, et al
    Comparison of the immunogenicity of two inactivated recombinant rabies viruses overexpressing the glycoprotein.
    Arch Virol. 2016.
    PubMed     Text format     Abstract available


    June 2016
  50. MENG XY, Luo Y, Liu Y, Shao L, et al
    A triplex real-time PCR for differential detection of classical, variant and Bartha-K61 vaccine strains of pseudorabies virus.
    Arch Virol. 2016.
    PubMed     Text format     Abstract available


  51. MORIMOTO K, Khawplod P, Sato Y, Virojanapirom P, et al
    Rabies vaccination at a virus-inoculated site as an alternative option to rabies immunoglobulin.
    Arch Virol. 2016.
    PubMed     Text format     Abstract available


  52. JAGADESH A, Salam AA, Mudgal PP, Arunkumar G, et al
    Influenza virus neuraminidase (NA): a target for antivirals and vaccines.
    Arch Virol. 2016.
    PubMed     Text format     Abstract available


  53. BALL C, Forrester A, Ganapathy K
    Detection of variant infectious bronchitis viruses in Sri Lanka (2012-2015).
    Arch Virol. 2016;161:1697-9.
    PubMed     Text format     Abstract available


  54. SVIBEN D, Forcic D, Kurtovic T, Halassy B, et al
    Stability, biophysical properties and effect of ultracentrifugation and diafiltration on measles virus and mumps virus.
    Arch Virol. 2016;161:1455-67.
    PubMed     Text format     Abstract available


    March 2016
  55. GE F, Li X, Ju H, Yang D, et al
    Genotypic evolution and antigenicity of H9N2 influenza viruses in Shanghai, China.
    Arch Virol. 2016.
    PubMed     Text format     Abstract available


  56. JIN H, Xia X, Liu B, Fu Y, et al
    High-yield production of canine parvovirus virus-like particles in a baculovirus expression system.
    Arch Virol. 2016;161:705-10.
    PubMed     Text format     Abstract available


    February 2016
  57. TEWAWONG N, Chansaenroj J, Klinfueng S, Vichiwattana P, et al
    Lineage-specific detection of influenza B virus using real-time polymerase chain reaction with melting curve analysis.
    Arch Virol. 2016.
    PubMed     Text format     Abstract available


    January 2016
  58. CHEN Y, He S, Sun L, Luo Y, et al
    Genetic variation, pathogenicity, and immunogenicity of highly pathogenic porcine reproductive and respiratory syndrome virus strain XH-GD at different passage levels.
    Arch Virol. 2016;161:77-86.
    PubMed     Text format     Abstract available


    September 2015
  59. LEI H, Peng X, Zhao D, Jiao H, et al
    Cross-protection of Lactococcus lactis-displayed HA2 subunit against homologous and heterologous influenza A viruses in mice.
    Arch Virol. 2015.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Vaccines is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: